AnaptysBio president and chief executive officer Hamza Suria has stepped down from his roles effective immediately, after a decade in these positions.
In addition to letting go of his executive functions, Suria will also be vacating his board director post. He will stay on in an advisory capacity.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,